KALSIOM SAS
www.kalsiom.comKALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need. The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes.
Read more
KALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need. The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes.
Read more
Country
City (Headquarters)
Brest
Industry
Employees
1-10
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Chairman Acting Chief Executive Officer and Co - Founder
Email ****** @****.comPhone (***) ****-****
Technologies
(7)
Reach decision makers at KALSIOM SAS
Free credits every month!
KALSIOM SAS FAQ
Brest, France
Biotechnology Research
